CaÑete, Alex D.

HRN: 25-85-81  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/11/2024
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
09/11/2024
09/25/2024
IVT
4.5g
Q8
CAP-HR
Waiting Final Action 
09/11/2024
AZITHROMYCIN 500MG TABLET (TAB)
09/11/2024
09/22/2024
NGT
500mg
OD
CAP-HR
Waiting Final Action 
09/23/2024
LEVOFLOXACIN 5MG/ML, 100ML (VIAL)
09/23/2024
09/30/2024
IV
750
OD
CAP
Waiting Final Action 
10/11/2024
CLINDAMYCIN 150MG/ML, 4ML (AMP)
10/11/2024
10/17/2024
IV
600mg
Q8h
CAP-HR
Waiting Final Action 
10/18/2024
CEFTAZIDIME 1GM (VIAL)
10/18/2024
10/24/2024
IV
1 Gram
Q 12
VAP
Waiting Final Action 
10/18/2024
CIPROFLOXACIN 500MG (TAB)
10/18/2024
10/24/2024
PO
750 Mg
Bid
Vap
Waiting Final Action 
10/19/2024
CEFTAZIDIME 1GM (VIAL)
10/19/2024
10/26/2024
IV
1gm
Q8
VAP
Waiting Final Action 
10/29/2024
CEFTAZIDIME 1GM (VIAL)
10/29/2024
11/12/2024
IV
2gm
Q8
Pseudomonas Pneumonia
Waiting Final Action 
10/29/2024
CIPROFLOXACIN 500MG (TAB)
10/29/2024
11/12/2024
PO
750mg
BID
Klebsiella Pneumonia
Waiting Final Action 
10/30/2024
MUPIROCIN 2%, 15G (TUBE)
10/30/2024
11/08/2024
TOPICAL
To Affected Area
BID
Decubitus Ulcer
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: